Emerald Health Therapeutics Inc.
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Canopy Growth to Get Extract Supply from MediPharm Labs
On November 29, Canopy Growth (WEED) entered an 18-month supply agreement with MediPharm Labs.
Cannabis Sector: Week Ended October 10 in Review
The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.
Cannabis Sector: The Week in Review for October 3
The cannabis sector was trading in the red for the week ended October 3. The sector’s ETFs broadly ended the week in negative territory.
Miracle-Gro, CannTrust, Emerald Health Stocks Surging
Scotts Miracle-Gro (SMG) reported its earnings this morning. Now SMG is surging alongside CannTrust and Emerald Health stocks. Here’s why.
Key Cannabis Sector Updates: Analyst Ratings and Earnings
Last week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%.
Jefferies Initiates Coverage of CGC, TRST, ACB, OGRMF, and More
Just last week, we saw Seaport Global initiate coverage on some of the big cannabis players in the industry. Early this morning, yet another firm initiated coverage of cannabis stocks.